Sakar Healthcare Complete Financial Statements
In FY2025, Sakar Healthcare (SAKAR) reported revenue ₹59 Cr, net profit ₹5 Cr and EPS ₹2.03, with a net profit margin of 8.5% and ROE of 1.7%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SAKAR company profile.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SAKAR Revenue, Net Profit & EBITDA — Year-on-Year Growth
SAKAR YoY (Sept 2024 vs Sept 2025) — revenue +37.2%, EBITDA +8.3%, expenses +48.4%.
SAKAR Income Statement — Revenue, EBITDA & Net Profit
Sakar Healthcare revenue ₹59 Cr, EBITDA ₹13 Cr, net profit ₹5 Cr, EPS ₹2.03 (2025) — net profit margin 8.5%. Explore SAKAR investment value to estimate fundamental worth using multiple valuation models.
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Jun 2020 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 59 | 50 | 53 | 71 | 43 | 44 | 42 | 44 | 35 | 43 | 41 | 38 | 31 | 38 | 29 | 35 | 32 | 22 | 31 | 30 | 26 | 20 | 27 |
| Expenses | 46 | 35 | 40 | 52 | 31 | 32 | 31 | 32 | 25 | 33 | 30 | 28 | 22 | 28 | 21 | 25 | 25 | 15 | 24 | 23 | 19 | 16 | 23 |
| EBITDA | 13 | 16 | 13 | 19 | 12 | 12 | 11 | 12 | 10 | 10 | 11 | 9 | 9 | 10 | 8 | 11 | 8 | 8 | 7 | 7 | 7 | 5 | 4 |
| Operating Profit Margin % | 20.00% | 31.00% | 24.00% | 26.00% | 27.00% | 25.00% | 26.00% | 27.00% | 27.00% | 19.00% | 23.00% | 24.00% | 28.00% | 25.00% | 28.00% | 26.00% | 22.00% | 33.00% | 21.00% | 22.00% | 27.00% | 23.00% | 14.00% |
| Depreciation | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 4 | 2 | 5 | 2 | 3 | 1 | 1 | 1 |
| Interest | 2 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 6 | 5 | 11 | 5 | 5 | 5 | 6 | 4 | 4 | 4 | 3 | 4 | 6 | 4 | 5 | 5 | 2 | 4 | 3 | 6 | 3 | 2 |
| Tax | 1 | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 3 | -3 | 1 | 1 | 3 | 1 | 0 | 3 | 1 | 1 | 1 |
| Net Profit | 5 | 6 | 5 | 10 | 5 | 3 | 2 | 5 | 4 | 4 | 3 | 2 | 2 | 9 | 3 | 4 | 3 | 2 | 4 | 0 | 5 | 3 | 2 |
| Earnings Per Share (₹) | 2.03 | 2.66 | 2.11 | 4.59 | 2.17 | 1.46 | 1.10 | 2.08 | 1.68 | 2.04 | 1.46 | 0.98 | 1.01 | 5.07 | 1.65 | 2.16 | 1.44 | 1.17 | 2.15 | 0.07 | 3.04 | 1.72 | 1.20 |
SAKAR Balance Sheet — Assets, Liabilities & Shareholders' Equity
SAKAR total assets ₹415 Cr, total equity ₹286 Cr, total liabilities ₹ Cr (2025) — ROE 1.7%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 415 | 389 | 336 | 268 | 178 | 115 |
| Current Assets | 89 | 72 | 56 | 50 | 34 | 22 |
| Fixed Assets | 309 | 314 | 267 | 205 | 69 | 66 |
| Capital Work in Progress | 17 | 0 | 7 | 1 | 49 | 13 |
| Investments | 0 | 0 | 3 | 7 | 0 | 0 |
| Other Assets | 90 | 74 | 60 | 55 | 60 | 36 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 67 | 67 | 109 | 94 | 46 | 20 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 286 | 262 | 173 | 128 | 99 | 81 |
| Share Capital | 22 | 22 | 19 | 17 | 16 | 15 |
| Reserves & Surplus | 261 | 236 | 154 | 110 | 83 | 66 |
SAKAR Cash Flow Statement — Operating, Investing & Financing
Sakar Healthcare operating cash flow ₹34 Cr, investing ₹-31 Cr, financing ₹-4 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 34 | 25 | 33 | 36 | 15 | 19 |
| Investing Activities | -31 | -52 | -74 | -90 | -47 | -22 |
| Financing Activities | -4 | 27 | 41 | 55 | 32 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |